The full article of ‘A #DeepLearning algorithm for fully automated volumetric measurement of #meningioma burden’ is now available in #NeuroOncology Advances: bit.ly/4qsK76c

Insights into professional well-being in neuro-oncology – recently published in Neuro-Oncology: Professional Grief, Burnout and Coping among Neuro-Oncologists: A Cross-Sectional Online Study (PROGRESS) The results will be presented at #EANO2026. 👉 pubmed.ncbi.nlm.nih.gov/42479169/ #EANOessentials

new out in Nature this week www.nature.com/articles/s41...

A prognostic human brain network for diffuse midline glioma - Nature

Tumour network mapping of diffuse midline glioma (DMG) defines a conserved and prognostically important brain network in children with DMG, consistent with the hypothesis that DMGs exploit otherw...

nature.com

Experts in Heidelberg have developed an AI system that can classify brain tumors with unprecedented accuracy using standard microscopic tissue sections. The system could accelerate the diagnosis of brain tumors worldwide. 🚀 t1p.de/fbfey

AI Diagnoses Brain Tumors in Minutes Instead of Weeks

Experts in Heidelberg have developed an AI system that can classify brain tumors with unprecedented accuracy using standard microscopic tissue sections. Using digitized standard stains, the system ide...

t1p.de

1/n Excited to share our new paper in Nature Cancer 🦀 Meet Hetairos (Greek- “companion”): an AI model that predicts >100 methylation-defined CNS tumour subtypes directly from a routine H&E slide 🧠 State of the art diagnostics- from the slide that’s already on every pathologists’ desk 🧵

👋 Students, Youngsters, Fellows, Postdocs, Nurses & AHP in #NeuroOncology! EANO invites you to register for the 21st Meeting of the European Association of Neuro-Oncology (#EANO2026) taking place from Sept 24-27, 2026 in Rome, IT. 👉 Register today! eano.eu/eano2026/reg... #btsm

In our new collaborative paper on IDHmutant glioma with the Tirosh, Suva, Iavarone and Lasorella labs, we show how acquired genetic alterations converge with cell state changes and poor treatment responses. www.nature.com/articles/s41...

Acquired genetic and cell-state changes in IDH-mutant glioma progression - Nature

Longitudinal transcriptomic, chromatin and genomic analyses of the two types of IDH-mutant glioma reveal in detail how disease progression is influenced by interdependent genetic, epigenetic and micro...

nature.com

‼️ Good news! Deadline for late-breaking abstract submission extended to June 09, 2026! Don't miss this opportunity to present your very latest reasearch breakthrough to the #NeuroOncology community at #EANO2026. Submit your abstract 👉 www.eano.eu/eano2025/abs... #btsm #braintumor

📣 It’s today! Registration for #EANO2026 is now open. Join us in #Rome (IT), Sept 24–27, 2026, and connect with leading experts in #NeuroOncology. 🎟 Early Bird fees available until July 7, 2026. 👉 eano.eu/eano2026/reg... #Neurosurgery #Neuroradiology #Neurology #Oncology #PalliativeCare #Nursing

I am thrilled to co-organize the upcoming Paris Neuro-Oncology Conference (January 27-29, 2027), alongside an exceptional group of colleagues and brain tumor experts. Abstracts by Sept 18, 2026 Join us in Paris to discuss the latest frontiers in neuro-oncology. my.weezevent.com/paris-neuro-...

Paris Neuro-Oncology Conference@pnoc2027.bsky.social · 3mo ago

📢 Registration is open for the Paris Neuro-Oncology Conference 🇫🇷🧠 🗓 Jan 27–29, 2027 | Paris 🎙 CALL FOR ABSTRACTS Early-career researchers are invited to submit abstracts for oral & poster sessions before Sept 18, 2026. 📩 contactpnoc@gmail.com 🔗 my.weezevent.com/paris-neuro-...

📢 #CancerNeuroscience Online Seminar with @michellemonje.bsky.social from Stanford University, USA. Title: The Neuroscience of Brain Cancers June 16, from 5-6 PM CEST, please register here: us06web.zoom.us/meeting/regi...

🧪 𝗡𝗼𝘄 𝗼𝗽𝗲𝗻: #𝗘𝗔𝗡𝗢 𝗘𝗹𝗲𝗰𝘁𝗶𝗼𝗻𝘀 Be part of the Scientific Committee and help drive innovation and collaboration in the field. Submit your application by May 28, 2026 and get involved. Learn more 👉 www.eano.eu #NeuroOncology #braintumor #btsm

Read more about @gelarehzadeh.bsky.social research on ‘Decoding the #immunological landscape of #meningioma to identify new #treatment targets’ with the Brain Tumour Charity: bit.ly/4m8n7aa

💡 Recently published in "Cell Reports Medicine": TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomas Open Access. Read more 🔗 t1p.de/wrciu @cellpress.bsky.social @angelodipa.bsky.social #EANOessentials #NeuroOncology #Oligodendrogliomas #OpenAccess

Congratulations!

Else Kröner-Fresenius-Stiftung@ekfstiftung.bsky.social · 5mo ago

Der Deutsche #Krebspreis 2026 geht u.a. an Prof. Felix Sahm, Universitätsklinikum Heidelberg (UKHD) sowie Wissenschaftler am Deutschen Krebsforschungszentrum in der Kategorie „Translationale Forschung“. Wir gratulieren und freuen uns, ihn auf seinem Weg begleitet zu haben. 🎉#EKFS

🗳️ #EANO Elections 2026–2028 are open! Shape the future of neuro-oncology by joining the EANO Executive Board or one of our key committees. We invite motivated EANO members to apply and actively contribute to our community. 🗓 Deadline: May 28, 2026 💻 Apply via EventsAir 👉 t1p.de/EANO-Election

New preprint alert! I'm excited to share our latest preprint where we investigate the underlying developmental causes of the male bias in the pediatric brain tumor Group 3/4 medulloblastoma. www.biorxiv.org/content/10.6...

⏰ The clock is ticking! Only 3 days left to submit your abstract for #EANO2026 in Rome. Share your research, engage in meaningful discussions, and expand your professional network. We look forward to your contributions! Submit your abstract now! eano.eu/eano2026/#btsm

‘A microenvironment-determined risk continuum refines #subtyping in #meningioma and reveals determinants of #MachineLearning-based tumor classification’ is now out in Nature Genetics: go.nature.com/4v2Hlq1

www.nature.com/articles/s41...

Modelling brain tumours with organoids: towards precision medicine in neuro-oncology - Nature Reviews Neurology

Organoids provide a useful model to capture the heterogeneity of brain tumours. Here, the authors assess current methodologies for generating organoids from various types of brain tumour and discuss h...

nature.com

📚 Recently published in @cellpress.bsky.social – insights into #immunotherapy in #glioblastoma: Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trial Full article: www.sciencedirect.com/science/arti... #EANOessentials

While the neuro-oncology community is gathering in Bucharest for inspiring #EANO events, the next highlight is already on the horizon. 🔬 Be part of #EANO2026 in Rome and present your research. Submit your abstract now: eano.eu/eano2026/abs... #NeuroOncology #BrainTumor #BTSM

Thank you to the many participants who joined the EANO–SNO Highlights Webinar 2025! Outstanding talks, engaging discussion, and key scientific insights from #EANO2025 & #SNO2025. 🎥 The full recording is now online on our YouTube channel – watch or rewatch anytime! 👉 youtu.be/REdE1Y8zQZQ?...

Webinar: 4th Annual SNO/EANO Highlights of 2025

YouTube video by EANO

youtu.be

Recently published in @cp-immunity.bsky.social: Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures. 👉 Full article: www.cell.com/immunity/ful... #NeuroOncology #Glioma #OpenAccess #EANOessentials

Presented at #EANO2025 and published in Neuro Oncology: Associations of supramaximal resection with outcome in glioblastoma across age groups: a report of the RANO resect group by Philipp Karschnia et al 👉 Learn more: doi.org/10.1093/neuo... #RANO #glioblastoma #surgery #EANOessentials

Associations of supramaximal resection with outcome in glioblastoma across age groups: A report of the RANO resect group

AbstractAbstract. BackgroundThe oncological role of resection in elderly patients with glioblastoma remains controversial. We evaluated the value of resect

doi.org

𝙍𝙚𝙢𝙞𝙣𝙙𝙚𝙧: 𝙍𝙚𝙜𝙞𝙨𝙩𝙚𝙧 𝙛𝙤𝙧 𝙩𝙝𝙚 𝙀𝘼𝙉𝙊 𝙏𝙪𝙢𝙤𝙧 𝘽𝙤𝙖𝙧𝙙 𝟐𝟎𝟐𝟔 Following the successful first edition in Prague, the 2nd #EANOTumorBoard will take place on March 12, 2026, in Bucharest, RO, just before the #EANO Seminars. 🗓️ Registration deadline: February 23, 2026 www.eano.eu/eanomeetings...

Daniel Kirschenbaum from the DKFZ is developing new methods to find out how immune cells are suppressed by malignant brain tumors. He is being supported in this by the EACR-Mark Foundation & the Pezcoller Foundation with the highly endowed Rising Star Award. @d-kirschenbaum.bsky.social t1p.de/zibl3

Highly endowed research award for DKFZ scientist

Daniel Kirschenbaum from the German Cancer Research Center (DKFZ) is developing new methods to find out exactly how immune cells are suppressed by malignant brain tumors. He is being supported in this...

t1p.de

First presented at #EANO2024, this work has now been published in Neuro-Oncology. 👉 academic.oup.com/neuro-oncolo... #NeuroOncology #EANO #Glioma #ResearchHighlights #EANOessentials @lukasbunse.bsky.social @venkataramanilab.bsky.social @wickwolfgang.bsky.social @michael-platten.bsky.social

Multimodality mapping of immunotherapy distribution as a predictive marker in glioma

AbstractBackground. Scarce T cell infiltration, immunosuppressive tumor-associated macrophages and ineffective drug delivery drive glioma progression and l

academic.oup.com

Coming soon: The #BrainConference on #CancerNeuroscience: 🗺️ Rungstedgaard (CPH,DM) 📅 25-28 Aug 2026 Please join chairs @michellemonje.bsky.social & Frank Winkler and an great line up of speakers to discuss the newest findings. Early bird registration is now open 👇 @fens.org #FENS #Neuroscience

The Brain Conference on CANCER NEUROSCIENCE - Federation of European Neuroscience Societies

fens.org

📣 Join the 4th Annual EANO/SNO Highlights Webinar Top abstracts from #EANO2025 (Prague) & #SNO2025 (Honolulu) – latest advances in neuro-oncology. 🗓 Feb 6, 2026 | ⏰ 18:30–19:30 CET 🎟 Free for #EANO & #SNO members 👉 Register now: bit.ly/EANO-SNO-2025 #NeuroOncology @neuroonc.bsky.social